Related Experiment Video
Updated: Aug 4, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Epigenetic versus genetic alterations in the inactivation of E-cadherin
1Cancer Research Campaign Department of Medical Oncology, CRC Beatson Laboratories, Glasgow University, Glasgow G61 1BD, UK. g.strathdee@beatson.gla.ac.uk
Abstract:
Genetic mutation of genes that inhibit the formation of tumours has long been known to be one of the main driving forces in the development of cancer. Inactivation of one such gene, E-cadherin, is thought to be an important step in the development of most, or all, epithelial derived tumour types. Mutations within the E-cadherin gene have been identified as the cause of familial gastric cancer and loss of expression of E-cadherin has been found to be widespread in sporadically occurring epithelial tumours. Despite this, mutations of the E-cadherin gene have been only rarely found in most types of sporadic cancers. However, recent evidence has identified a second mechanism potentially responsible for inactivation of E-cadherin, and other important genes, during tumourigenesis, namely DNA methylation. This review will examine the importance of genetic (mutation) versus epigenetic (DNA methylation) mechanisms in the inactivation of E-cadherin during tumour development and also discuss potential differences in the functional consequences between inactivation by epigenetic or genetic means.
Insights
Cancer develops from gene mutations that stop tumor formation. E-cadherin gene inactivation, via mutation or DNA methylation, is crucial in epithelial cancers, with distinct functional consequences.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Tumor suppressor gene inactivation is a key driver of cancer.
- E-cadherin is critical for epithelial cell adhesion and its loss is implicated in many epithelial cancers.
- While E-cadherin mutations cause familial gastric cancer, they are rare in sporadic tumors.
Purpose of the Study:
- To review the roles of genetic mutation versus epigenetic DNA methylation in E-cadherin inactivation.
- To explore potential functional differences between genetic and epigenetic inactivation of E-cadherin.
- To understand the implications for epithelial tumor development.
Main Methods:
- Literature review of genetic and epigenetic mechanisms affecting E-cadherin.
- Analysis of studies on E-cadherin mutations and DNA methylation in various cancers.
- Comparison of functional consequences of different inactivation pathways.
Main Results:
- E-cadherin inactivation is vital in epithelial tumor development.
- DNA methylation presents an alternative mechanism to mutation for E-cadherin inactivation in sporadic cancers.
- Functional outcomes may differ based on whether inactivation is genetic or epigenetic.
Conclusions:
- Both genetic mutations and epigenetic DNA methylation contribute to E-cadherin inactivation during tumorigenesis.
- DNA methylation is a significant factor in sporadic epithelial cancers where mutations are infrequent.
- Understanding these distinct inactivation mechanisms is important for cancer research and potential therapeutic strategies.
Related Concept Videos
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Structure of Cadherins
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

